Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 3, 2018
Antibody-based cell-surface proteome profiling of metastatic breast cancer primary explants and cell linesVera S Donnenberg, Jayce Jieming Zhang, Erika Moravcikova, et al.
Frontiers in Immunology|October 30, 2024
Real-world study and prognostic analysis of angioimmunoblastic T-cell lymphomaSuxiao Li, Xiaoyan Feng, Yunfei Song, et al.
Frontiers in Immunology|June 3, 2022
Clinical and Molecular Characteristics of 60 Patients With Human Immunodeficiency Virus-Negative Castleman DiseaseSiyu Qian, Mengjie Ding, Huting Hou, et al.
Frontiers in Endocrinology|November 17, 2022
Description of the molecular and phenotypic spectrum in Chinese patients with aggrecan deficiency: Novel <i>ACAN</i> heterozygous variants in eight Chinese children and a review of the literatureShuyun Deng, Lele Hou, Dan Xia, et al.
Frontiers in Genetics|July 12, 2021
Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric CancerWeiyu Dai, Yizhi Xiao, Weimei Tang, et al.
Pathogens (Basel, Switzerland)|November 18, 2020
A Novel Subunit Vaccine Based on Outer Capsid Proteins of Grass Carp Reovirus (GCRV) Provides Protective Immunity against GCRV Infection in Rare Minnow (<i>Gobiocypris rarus</i>)Changyong Mu, Vikram N Vakharia, Yong Zhou, et al.
Aging|January 5, 2024
Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcomaMengjie Ding, Xianting Ran, Siyu Qian, et al.
American Journal of Medical Genetics. Part A|February 9, 2023
ARID2, a rare cause of Coffin-Siris syndrome: A novel microdeletion at 12q12q13.11 causing severe short stature and literature reviewDan Xia, Shuyun Deng, Chenchen Gao, et al.
Cell Death & Disease|December 21, 2021
USP3 promotes gastric cancer progression and metastasis by deubiquitination-dependent COL9A3/COL6A5 stabilisationXiaosheng Wu, Hao Wang, Danping Zhu, et al.
Drug Design, Development and Therapy|March 12, 2020
Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective StudyXinran Ma, Ling Li, Lei Zhang, et al.
Pageof 7